Bills › 88th General Assembly

SF 2384Died when the session ended · February 24, 2020

Relating to insurance coverage for prescription drugs used in the treatment of stage IV cancer, and including applicability provisions

Sponsored by the Senate Human Resources Committee

Topics:Health care

Same legislation: SSB 3161

Where it is now

  1. Done: IntroducedFebruary 12, 2020
  2. Done: SubcommitteeFebruary 13, 2020
  3. Done: Senate committeeFebruary 19, 2020
  4. Stopped: Passes the SenateDied when the General Assembly ended
  5. Next: House committee
  6. Next: Passes the House
  7. Next: To the Governor
  8. Next: Signed into law

Died when the session ended The 2020 session adjourned on June 14, 2020, the General Assembly’s last regular session. Bills that didn’t pass both chambers died. What’s a funnel?

What’s in it

AI summary Health insurance plans must cover prescription drugs used to treat stage IV cancer. These plans cannot require patients to try different, cheaper drugs first before covering an FDA-approved cancer medication. While the rules for cancer drugs are strict, insurance companies can still use step therapy for drugs used to treat side effects or related symptoms.1

Read the official explanation

This bill relates to insurance coverage for prescription drugs used in the treatment of stage IV cancer. The bill requires policies, contracts, or plans providing for third-party payment or prepayment of health or medical expenses that provide coverage for prescription drugs to provide coverage for prescription cancer drugs. “Prescription cancer drug” is defined in the bill as a prescription drug that is used to treat stage IV cancer. “Stage IV cancer” is also defined in the bill. The policy, contract, or plan is required to provide coverage, without imposing a step therapy protocol, for a prescription cancer drug that has been approved by the United States food and drug administration, the use of which is in accordance with medical standards of care for stage IV cancer, and the use of which is supported by peer-reviewed, evidence-based literature. The policy, contract, or plan must provide coverage, and may impose a step therapy protocol, for a prescription drug that is used to treat “associated conditions”. “Associated conditions” is defined in the bill as symptoms or side effects associated with stage IV cancer, or with the health care services for stage IV cancer provided by a covered person’s health care professional. “Step therapy protocol” is defined in the bill as a protocol or program that establishes a specific sequence in which prescription drugs for a specified medical condition and medically appropriate for a particular covered person are covered under a pharmacy or medical benefit by a health carrier, a health benefit plan, or a utilization review organization, including self-administered drugs and drugs administered by a health care professional. The bill applies to the third-party payment providers enumerated in the bill. The bill specifies the types of specialized health-related insurance which are not subject to the coverage requirements of the bill. The commissioner of insurance may adopt rules to administer the requirements of the bill. The provisions of the bill are applicable to third-party payment provider contracts, policies, or plans delivered, issued for delivery, continued, or renewed in this state on or after January 1, 2021.

Full bill text2

Senate subcommittee

Named February 13, 2020 (as SSB 3161). On February 19, 2020 it recommended amendment and passage.

Three legislators hear a bill first and recommend what the committee should do; it’s the best time to weigh in. How to take part

Iowa Code it changes

Creates§514C.24A

How the Code works3

Lobbying

3 for · 1 against · 11 undecided · Who →

Family tree

Earlier and later bills are matched by wording or an identical title.

Similar bills

  • HF 873 Relating to insurance coverage for prescription drugs used in the treatment of stage IV ca…
    89th General Assembly · In committee
    Nearly identical
  • SSB 1009 SSB 1009
    90th General Assembly · Subcommittee recommends passage
    Very similar
  • SF 197 Relating to insurance coverage for prescription drugs used in the treatment of metastatic …
    91st General Assembly · Subcommittee recommends passage
    Very similar
  • SF 116 Relating to insurance coverage for prescription drugs used in the treatment of metastatic …
    89th General Assembly · In committee
    Very similar
  • SF 2165 Relating to insurance coverage for prescription drugs used in the treatment of metastatic …
    89th General Assembly · In committee
    Very similar
  • SF 2216 Relating to insurance coverage for diagnostic breast cancer examinations and prescription …
    88th General Assembly · In committee
    Similar

Matched by wording or an identical title.